Infectious Diseases in Critical Care Medicine

37. Cameron JL, Reynolds J, Zuidema GD. Aspiration in patients with tracheostomies. Surg Gynecol
    Obstet 1973; 136(1):68–70.


38. du Moulin GC, Paterson DG, Hedley-Whyte J, et al. Aspiration of gastric bacteria in antacid-treated
    patients: a frequent cause of postoperative colonisation of the airway. Lancet 1982; 1(8266):242–245.


39. Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing
    ventilator-associated pneumonia. Ann Intern Med 1995; 122(3):179–186.


40. Niederman MS. Gram-negative colonization of the respiratory tract: pathogenesis and clinical
    consequences. Semin Respir Infect 1990; 5(3):173–184.


41. Inglis TJ, Sherratt MJ, Sproat LJ, et al. Gastroduodenal dysfunction and bacterial colonisation of the
    ventilated lung. Lancet 1993; 341(8850):911–913.


42. Niederman MS, Mantovani R, Schoch P, et al. Patterns and routes of tracheobronchial colonization in
    mechanically ventilated patients. The role of nutritional status in colonization of the lower airway by
    Pseudomonasspecies. Chest 1989; 95(1):155–161.


43. Cardenosa Cendrero JA, Sole-Violan J, Bordes Benitez A, et al. Role of different routes of tracheal
    colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest
    1999; 116(2):462–470.


44. Berthelot P, Grattard F, Mahul P, et al. Prospective study of nosocomial colonization and infection
    due toPseudomonas aeruginosain mechanically ventilated patients. Intensive Care Med 2001; 27(3):
    503–512.


45. Guideline for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention.
    Respir Care 1994; 39(12):1191–1236.


46. Weber DJ, Rutala WA, Sickbert-Bennett EE, et al. Microbiology of ventilator-associated pneumonia
    compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2007; 28(7):
    825–831.


47. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among
    patients with ventilator-associated pneumonia. Chest 2006; 129(5):1210–1218.


48. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially
    drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157(2):531–539.


49. Gaynes R. Health care–associated bloodstream infections: a change in thinking. Ann Intern Med
    2002; 137(10):850–851.


50. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with
    community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and
    prevention. Am J Respir Crit Care Med 2001; 163(7):1730–1754.


51. Rello J, Sa-Borges M, Correa H, et al. Variations in etiology of ventilator-associated pneumonia
    across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit
    Care Med 1999; 160(2):608–613.


52. Shorr AF, Zilberberg MD, Micek ST, et al. Prediction of infection due to antibiotic-resistant bacteria
    by select risk factors for health care–associated pneumonia. Arch Intern Med 2008; 168(20):
    2205–2210.


53. El-Solh AA, Sikka P, Ramadan F, et al. Etiology of severe pneumonia in the very elderly. Am J Respir
    Crit Care Med 2001; 163(3 Pt 1):645–651.


54. Fridkin SK, Edwards JR, Tenover FC, et al. Antimicrobial resistance prevalence rates in hospital
    antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections.
    Clin Infect Dis 2001; 33(3):324–330.


55. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia byStaphylococcus aureus.
    Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med
    1994; 150(6 Pt 1):1545–1549.


56. Vidaur L, Sirgo G, Rodriguez AH, et al. Clinical approach to the patient with suspected ventilator-
    associated pneumonia. Respir Care 2005; 50(7):965–974.


57. Baraibar J, Correa H, Mariscal D, et al. Risk factors for infection byAcinetobacter baumanniiin
    intubated patients with nosocomial pneumonia. Chest 1997; 112(4):1050–1054.


58. Montero A, Corbella X, Ariza J. Clinical relevance ofAcinetobacter baumanniiventilator-associated
    pneumonia. Crit Care Med 2003; 31(10):2557–2559.


59. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, et al. Treatment of multidrug-resistant
    Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a
    comparison with imipenem-susceptible VAP. Clin Infect Dis 2003; 36(9):1111–1118.


60. Garnacho J, Sole-Violan J, Sa-Borges M, et al. Clinical impact of pneumonia caused byAcinetobacter
    baumanniiin intubated patients: a matched cohort study. Crit Care Med 2003; 31(10):2478–2482.


61. Dore P, Robert R, Grollier G, et al. Incidence of anaerobes in ventilator-associated pneumonia with
    use of a protected specimen brush. Am J Respir Crit Care Med 1996; 153(4 Pt 1):1292–1298.

198 Bouza and Burillo